Navigation Links
Early Alzheimer's Hinders Brain's Effort to Sort Information
Date:5/4/2009

Finding may encourage docs to 'train' patients to recall important facts

MONDAY, May 4 (HealthDay News) -- Difficulty distinguishing between important and less important information begins in the earliest stages of Alzheimer's disease, U.S. researchers report.

They add that the finding may encourage doctors to train people in the early stages of Alzheimer's how to better remember important information.

The study included 109 healthy older adults (average age 75), 41 people with very early Alzheimer's disease (average age 76), 13 people with early Alzheimer's (average age 77), and 35 younger adults (average age 20).

All the participants were asked to study and learn new words that were randomly assigned different point values. They were then asked to recall the words and maximize the total value while doing so. All the participants recalled more high-value words than low-value words, but the Alzheimer's patients were less able to remember items according to their value.

This shows that Alzheimer's patients no longer maximize learning and memory, which is a fairly efficient process in healthy people, said the researchers, from the University of Washington in St. Louis. They noted that Alzheimer's may make it more difficult for people to encode what they learn in a strategic way.

The study appears in the May issue of Neuropsychology.

More information

The U.S. National Institute on Aging has more about Alzheimer's disease.



-- Robert Preidt



SOURCE: American Psychological Association, news release, May 4, 2009


'/>"/>
Copyright©2009 ScoutNews,LLC.
All rights reserved  

Page: 1

Related medicine news :

1. Early Detection of Melanoma Plus Regular Skin Exams is Vital For Beating Disease
2. Memory grows less efficient very early in Alzheimers disease
3. JCI online early table of contents: May 1, 2009
4. Survey finds nearly half of Americans concerned they or their family may get sick from swine flu
5. Driven by Sales of Enbrel, Remicade and Humira, spondyloarthropathies Drug Market Grew to Nearly $2 Billion in 2008
6. First 10-year follow-up shows that treatment with AVONEX leads to long-term benefits in early multiple sclerosis patients
7. First ten-year follow-up shows that treatment with AVONEX leads to long-term benefits in early multiple sclerosis patients
8. New Analyses from 16-Year Follow-up Trial with Betaseron(R) Demonstrated that Early and Sustained Treatment of Multiple Sclerosis Patients Enrolled in the Trial Affected Their Long-term Outcomes
9. TypeAMom.net on Early Intervention for Autism
10. Radiation device in the breast reduces complications for early stage breast cancer patients
11. Early-stage lung cancer identified using computer-aided system
Post Your Comments:
*Name:
*Comment:
*Email:
Related Image:
Early Alzheimer's Hinders Brain's Effort to Sort Information
(Date:9/22/2017)... ... 22, 2017 , ... Silicon Valley startup Enke Life has ... Their electric toothbrushes aggressively attack oral bacteria by reducing dental plaque and other ... edge Enke technology with a premium timeless design, they want to redefine the ...
(Date:9/22/2017)... ... September 22, 2017 , ... Egg ... life. Although frozen embryos have a slight statistical advantage for live births, frozen ... a wonderful opportunity for women undergoing medical treatment or who are concerned about ...
(Date:9/21/2017)... ... September 21, 2017 , ... Process Capability Indices for ... 3:00 p.m. ET, http://www.fdanews.com/processcapabilityindices      , Quality in device ... of The Quality System Regulation (§820.250), and Devicemakers find themselves staring at a ...
(Date:9/21/2017)... ... September 21, 2017 , ... ... of a new member survey conducted by the International Society of Hair ... from 2014 to 2016 rose 60 percent, with 635,189 procedures performed in 2016. ...
(Date:9/21/2017)... ... 21, 2017 , ... Innovatum will demonstrate capabilities of fully ... Conference 2017 in Chicago, IL on October 17-19, 2017. This unique development addresses ... patient safety. , Microscan , a global technology leader in barcoding, ...
Breaking Medicine News(10 mins):
(Date:9/6/2017)... , Sept. 6, 2017 Eli Lilly and ... will present new data for galcanezumab and lasmiditan, two ... the International Headache Society (IHC) taking place Sept. 7-10 ... Lilly will highlight new, long-term data from an open-label ... of galcanezumab (120 mg and 240 mg) for the ...
(Date:9/5/2017)... , Sept. 5, 2017 Oramed Pharmaceuticals Inc. ... ), a clinical-stage pharmaceutical company focused on the development ... has successfully concluded its meeting with the U.S. Food ... oral insulin formulation. ... the regulatory pathway for submission of ORMD-0801, would be ...
(Date:8/29/2017)... , Aug. 29, 2017 ivWatch, LLC, the leading provider ... infiltrations, announced it has been awarded an Innovative Technology contract from ... the country. ... device to aid in the early detection of peripheral IV infiltration ... The Innovative Technology contract ...
Breaking Medicine Technology: